By Finance Pulse in U.S. —

Pfizer Alters Timeline for Drug Approval Plans

Pfizer changes plans for US and European drug approval, initially set for early 2025. Explore the implications of this strategic shift.

A sleek, modern office setting with a digital calendar displaying a revised date, symbolizing Pfizer
Pfizer Alters Timeline for Drug Approval Plans

Pfizer had expected to file for US and European approval of the drug in early 2025, but announced a change in plans.

Source